Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Microvascular Invasion in HCC: The Molecular Imaging Perspective.

Cuccurullo V, Di Stasio GD, Mazzarella G, Cascini GL.

Contrast Media Mol Imaging. 2018 Oct 4;2018:9487938. doi: 10.1155/2018/9487938. eCollection 2018. Review.

2.

Nuclear Medicine in Prostate Cancer: A New Era for Radiotracers.

Cuccurullo V, Di Stasio GD, Mansi L.

World J Nucl Med. 2018 Apr-Jun;17(2):70-78. doi: 10.4103/wjnm.WJNM_54_17. Review.

3.

Will 68Ga PSMA-radioligands be the only choice for nuclear medicine in prostate cancer in the near future? A clinical update.

Cuccurullo V, di Stasio GD, Evangelista L, Ciarmiello A, Mansi L.

Rev Esp Med Nucl Imagen Mol. 2018 Mar - Apr;37(2):103-109. doi: 10.1016/j.remn.2017.10.008. Epub 2018 Feb 13. Review. English, Spanish.

PMID:
29422356
4.

Is there a clinical usefulness for radiolabeled somatostatin analogues beyond the consolidated role in NETs?

Cuccurullo V, Di Stasio GD, Prisco MR, Mansi L.

Indian J Radiol Imaging. 2017 Oct-Dec;27(4):509-516. doi: 10.4103/ijri.IJRI_431_16.

5.

Radioguided thyroidectomy for follicular tumors: Multicentric experience.

Parmeggiani D, Gambardella C, Patrone R, Polistena A, De Falco M, Ruggiero R, Cirocchi R, Sanguinetti A, Cuccurullo V, Accardo M, Avenia N, Docimo G, Tolone S, Bassi V, Docimo L, Conzo G.

Int J Surg. 2017 May;41 Suppl 1:S75-S81. doi: 10.1016/j.ijsu.2017.03.081.

PMID:
28506419
6.

Nuclear Medicine in Patients with NET: Radiolabeled Somatostatin Analogues and their Brothers.

Cuccurullo V, Prisco MR, Di Stasio GD, Mansi L.

Curr Radiopharm. 2017;10(2):74-84. doi: 10.2174/1874471010666170323115136. Review.

PMID:
28332450
7.

Radioguided surgery with radiolabeled somatostatin analogs: not only in GEP-NETs.

Cuccurullo V, Di Stasio GD, Mansi L.

Nucl Med Rev Cent East Eur. 2017;20(1):49-56. doi: 10.5603/NMR.2017.0003. Review.

8.

Biochemical and Pathophysiological Premises to Positron Emission Tomography With Choline Radiotracers.

Cuccurullo V, Di Stasio GD, Evangelista L, Castoria G, Mansi L.

J Cell Physiol. 2017 Feb;232(2):270-275. doi: 10.1002/jcp.25478. Epub 2016 Jul 18. Review.

PMID:
27381438
9.

Targeted Therapy Towards Cancer-A Perspective.

Kitson SL, Cuccurullo V, Ciarmiello A, Mansi L.

Anticancer Agents Med Chem. 2017;17(3):311-317. doi: 10.2174/1871520616666160926115008. Review.

PMID:
27671296
10.

Small-Animal Molecular Imaging for Preclinical Cancer Research: .μPET and μ.SPECT.

Cuccurullo V, Di Stasio GD, Schillirò ML, Mansi L.

Curr Radiopharm. 2016;9(2):102-13. Review.

PMID:
26503290
11.

¹⁸F-fluoromethylcholine or ¹⁸F-fluoroethylcholine pet for prostate cancer imaging: which is better? A literature revision.

Evangelista L, Cervino AR, Guttilla A, Zattoni F, Cuccurullo V, Mansi L.

Nucl Med Biol. 2015 Apr;42(4):340-8. doi: 10.1016/j.nucmedbio.2014.12.019. Epub 2015 Jan 7. Review.

PMID:
25618796
12.

Diagnostic imaging in neuroendocrine tumors.

Mansi L, Cuccurullo V.

J Nucl Med. 2014 Oct;55(10):1576-7. doi: 10.2967/jnumed.114.147082. Epub 2014 Sep 18. No abstract available.

13.

Hybrid SPECT/CT imaging in neurology.

Ciarmiello A, Giovannini E, Meniconi M, Cuccurullo V, Gaeta MC.

Curr Radiopharm. 2014;7(1):5-11. Review.

PMID:
25143053
14.

Is radiocholine PET/CT already clinically useful in patients with prostate cancer?

Mansi L, Cuccurullo V, Evangelista L.

J Nucl Med. 2014 Sep;55(9):1401-3. doi: 10.2967/jnumed.114.142679. Epub 2014 Jul 24. No abstract available.

15.

Role of PET and SPECT in the study of amyotrophic lateral sclerosis.

Cistaro A, Cuccurullo V, Quartuccio N, Pagani M, Valentini MC, Mansi L.

Biomed Res Int. 2014;2014:237437. doi: 10.1155/2014/237437. Epub 2014 Apr 10. Review.

16.

From Homo sapiens to Homo in nexu (connected man): could functional imaging redefine the brain of a "new human species"?

Mansi L, Cuccurullo V, Ciarmiello A.

Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1385-7. doi: 10.1007/s00259-014-2765-z. No abstract available.

PMID:
24737118
17.

18FDG-PET/CT in traumatic brain injury patients: the relative hypermetabolism of vermis cerebelli as a medium and long term predictor of outcome.

Lupi A, Bertagnoni G, Borghero A, Picelli A, Cuccurullo V, Zanco P.

Curr Radiopharm. 2014;7(1):57-62.

PMID:
24725131
18.

Structural, pathophysiological and clinical aspects of diagnostic imaging in breast recurrence: the breast after treatment.

Cuccurullo V, Cascini GL, Mansi L.

Q J Nucl Med Mol Imaging. 2013 Dec;57(4):322-31. Review.

19.

18FNa-fluoride has a higher extraction with respect to 99mTc-methylene diphosphonate: mismatch in a case of meningioma.

Cascini GL, Cuccurullo V, Mansi L.

Rev Esp Med Nucl Imagen Mol. 2014 Jan-Feb;33(1):52-3. doi: 10.1016/j.remn.2013.04.004. Epub 2013 Aug 31. No abstract available.

20.

Radionuclide antibody-conjugates, a targeted therapy towards cancer.

Kitson SL, Cuccurullo V, Moody TS, Mansi L.

Curr Radiopharm. 2013 Jun 6;6(2):57-71. Review.

PMID:
23808764
21.

Peptide imaging with somatostatin analogues: more than cancer probes.

Cascini GL, Cuccurullo V, Tamburrini O, Rotondo A, Mansi L.

Curr Radiopharm. 2013 Mar;6(1):36-40. Review.

PMID:
23470033
22.

Bone metastases radiopharmaceuticals: an overview.

Cuccurullo V, Cascini GL, Tamburrini O, Rotondo A, Mansi L.

Curr Radiopharm. 2013 Mar;6(1):41-7. Review.

PMID:
23470032
23.

Questions and answers: what can be said by diagnostic imaging in neuroendocrine tumors?

Cuccurullo V, Faggiano A, Scialpi M, Cascini GL, Piunno A, Catalano O, Colao A, Mansi L.

Minerva Endocrinol. 2012 Dec;37(4):367-77. Review.

PMID:
23235192
24.

[Evaluation of the small bowel with computed tomography enteroclysis: technical applications and clinical indications].

Cioce F, Raucci A, Fontanarosa A, Pizza NL, Cuccurullo V, Stabile Ianora AA, Rubini G.

Recenti Prog Med. 2012 Nov;103(11):455-8. doi: 10.1701/1166.12888. Italian.

PMID:
23096731
25.

[Dw-MRI and bone scintigraphy in monitoring radio-therapy response in bone metastases].

Raucci A, Gatta G, Cuccurullo V.

Recenti Prog Med. 2012 Nov;103(11):438-43. doi: 10.1701/1166.12885. Italian.

PMID:
23096728
26.

[Role of nuclear imaging in the management and follow-up of patients with inflammatory bowel disease].

Scardapane A, Stabile Ianora AA, Cuccurullo V, Pizza NL, Capasso R, Gatta G.

Recenti Prog Med. 2012 Nov;103(11):431-4. doi: 10.1701/1166.12883. Review. Italian.

PMID:
23096726
27.

[Gastroenteric diseases in the third millennium: a rational approach to optimal imaging technique and patient selection].

Cuccurullo V, Cioce F, Sica A, Iasiello F, Capasso R, Gatta G, Rubini G.

Recenti Prog Med. 2012 Nov;103(11):426-30. doi: 10.1701/1166.12882. Review. Italian.

PMID:
23096725
28.

[Actual role of MR in the small bowel studies: dynamic sequences and bowel distension].

Stabile Ianora AA, Losco M, Fonio P, Zeppa P, Pizza NL, Cuccurullo V.

Recenti Prog Med. 2012 Nov;103(11):422-5. doi: 10.1701/1166.12881. Review. Italian.

PMID:
23096724
29.

[Inflammatory bowel disease: possibilities and limits in multidetector computed tomography].

Gatta G, Cioce F, Fontanarosa A, Raucci A, Cuccurullo V, Zeppa P, Rubini G.

Recenti Prog Med. 2012 Nov;103(11):417-21. doi: 10.1701/1166.12880. Review. Italian.

PMID:
23096723
30.

The dive response redefined: underwater behavior influences cardiac variability in freely diving dolphins.

Noren SR, Kendall T, Cuccurullo V, Williams TM.

J Exp Biol. 2012 Aug 15;215(Pt 16):2735-41. doi: 10.1242/jeb.069583.

31.

PET/MRI and the revolution of the third eye.

Mansi L, Ciarmiello A, Cuccurullo V.

Eur J Nucl Med Mol Imaging. 2012 Oct;39(10):1519-24. No abstract available.

PMID:
22801732
32.

Toward tailored medicine (and beyond): the phaeochromocytoma and paraganglioma model.

Cuccurullo V, Mansi L.

Eur J Nucl Med Mol Imaging. 2012 Aug;39(8):1262-5. doi: 10.1007/s00259-012-2156-2. Epub 2012 May 30. No abstract available.

PMID:
22644715
33.

Pathophysiological premises to radiotracers for bone metastases.

Cuccurullo V, Cascini G, Rossi A, Tamburrini O, Rotondo A, Mansi L.

Q J Nucl Med Mol Imaging. 2011 Aug;55(4):353-73. Review.

PMID:
21738112
34.

Less frequent requests for In-111 pentreotide and its brothers of endocrinological interest.

Cuccurullo V, Cascini GL, Tamburrini O, Mansi L, Rotondo A.

Minerva Endocrinol. 2011 Mar;36(1):41-52. Review.

PMID:
21460786
35.

Nuclear medicine in multiple myeloma -- more than diagnosis.

Cascini GL, Cuccurullo V, Tamburrini O, Mansi L, Rotondo A.

Nucl Med Rev Cent East Eur. 2010;13(1):32-8. Review.

PMID:
21154314
36.

Inflammatory bowel disease: value in diagnosis and management of MDCT-enteroclysis and 99mTc-HMPAO labeled leukocyte scintigraphy.

Grassi R, Rambaldi PF, Di Grezia G, Mansi L, Cuccurullo V, Cirillo A, Riegler G, Cappabianca S, Rotondo A.

Abdom Imaging. 2011 Aug;36(4):372-81. doi: 10.1007/s00261-010-9652-2.

PMID:
20963584
37.

Our experience in thymic hyperplasia using 67Ga-citrate, 111In-pentetreotide and 201Tl-chloride.

Rambaldi PF, Cuccurullo V, Cascini GL, Mansi L.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1616. doi: 10.1007/s00259-010-1487-0. Epub 2010 May 27. No abstract available.

PMID:
20505931
38.

The non tumour uptake of (111)In-octreotide creates new clinical indications in benign diseases, but also in oncology.

Cascini GL, Cuccurullo V, Mansi L.

Q J Nucl Med Mol Imaging. 2010 Feb;54(1):24-36. Review.

39.

Scintigraphic evaluation of oesophageal transit during radiotherapy to the mediastinum.

Sasso G, Rambaldi P, Sasso FS, Cuccurullo V, Murino P, Puntieri P, Marsiglia HR, Mansi L.

BMC Gastroenterol. 2008 Nov 5;8:51. doi: 10.1186/1471-230X-8-51.

40.

Plurifocal breast cancer and double lymphatic spread.

Ruggiero R, Procaccini E, Cuccurullo V, Mansi L, Gili S, Cremone C, Docimo G, Docimo L, Sparavigna L, Gubitosi A, Iovino F, Parmeggiani D, Avenia N.

G Chir. 2008 Oct;29(10):424-6.

PMID:
18947466
41.

Whole stomach transposition without gastric drainage procedure: a good surgical option to restore digestive continuity after esophagectomy.

Maffettone V, Rossetti G, Rambaldi P, Russo F, Cuccurullo V, Brusciano L, del Genio G, Russo G, Pizza F, Mansi L, del Genio A.

Int Surg. 2007 Mar-Apr;92(2):73-7.

PMID:
17518247
42.

Parotid function after selective deep lobe parotidectomy.

Colella G, Giudice A, Rambaldi P, Cuccurullo V.

Br J Oral Maxillofac Surg. 2007 Mar;45(2):108-11. Epub 2006 Jun 19.

PMID:
16782244
43.

Surgical treatment of differentiated thyroid carcinoma: a retrospective study.

Sperlongano P, Parmeggiani D, Pisaniello D, De Falco M, Sordelli I, Accardo M, Cuccurullo V, Mansi L, Tartaro GP, Barbarisi A, Avenia N, Parmeggiani U.

Front Biosci. 2006 Sep 1;11:2206-12.

PMID:
16720307
44.

[Radio-guided surgery in follicular neoplasms of the thyroid].

De Falco M, Parmeggiani D, Oliva G, Podio P, Miranda A, Di Benedetto A, Accardo M, Cuccurullo V, Mansi L, Docimo G, Parmeggiani U.

Suppl Tumori. 2005 May-Jun;4(3):S160-7. Italian. No abstract available.

PMID:
16437965
45.

Continuous monitoring of left ventricle function by VEST in hemodialyzed patients.

Cuccurullo V, Stellato D, Rambaldi PF, Spadafora M, De Santo NG, Cirillo M, Mansi L.

Semin Nephrol. 2006 Jan;26(1):80-4.

PMID:
16412832
46.

The present and future role of (111)In pentetreotide in the PET era.

Rambaldi PF, Cuccurullo V, Briganti V, Mansi L.

Q J Nucl Med Mol Imaging. 2005 Sep;49(3):225-35. Review.

47.

Nuclear medicine in emergency.

Mansi L, Rambaldi PF, Cuccurullo V, Varetto T.

Q J Nucl Med Mol Imaging. 2005 Jun;49(2):171-91. Review.

48.

Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer.

Mansi L, Moncayo R, Cuccurullo V, Dottorini ME, Rambaldi PF.

Q J Nucl Med Mol Imaging. 2004 Jun;48(2):82-95. Review.

49.

The development of diving bradycardia in bottlenose dolphins (Tursiops truncatus).

Noren SR, Cuccurullo V, Williams TM.

J Comp Physiol B. 2004 Mar;174(2):139-47. Epub 2003 Nov 25.

PMID:
14639484
50.

[Modulation of the axillary lymph node dissection in breast cancer].

Procaccini E, Ruggiero R, Mansi L, Laprovitera AP, Rambaldi PF, Cuccurullo V, Ferrara A, Procaccini F, Zenone P.

Ann Ital Chir. 2003 Jan-Feb;74(1):21-8; discussion 28-9. Italian.

PMID:
12870278

Supplemental Content

Loading ...
Support Center